An ionic contrast agent inhibits platelet-dependent thrombin generation and boosts the effect of abciximab.

R. al Dieri, E.D. de Muinck, H.C. Hemker, S. Béguin

Research output: Contribution to journalArticleAcademicpeer-review

303 Downloads (Pure)
Original languageEnglish
Pages (from-to)944-945
JournalThrombosis and Haemostasis
Volume85
DOIs
Publication statusPublished - 1 Jan 2001

Cite this